Remarkably, while stable TP53-mutated AML cells had decreased OXPHOS in this study, cytarabine induced an increase in OXPHOS, and the mevalonate pathway was found to play a significant role in these changes [25]. Here, TP53 is linked to acute myeloid leukemia.